Tonocard

Active Ingredient(s): Tocainide
FDA Approved: * November 9, 1984
Pharm Company: * ASTRAZENECA
Category: Irregular Heartbeat (Arrhythmia)

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Tonocard Overview

Tocainide (Tonocard) is a class Ib antiarrhythmic agent. It is no longer sold in the United States. Contents 1 Pharmacokinetics 2 Synthesis 3 References 4 External links Pharmacokinetics Tocainide is a lidocaine analog, that does not have significant 1st pass metabolism. It is found in two enantiomers. The R isomer is 4x as potent as the S. Oral bioavailability is 0.9-1.0. In the blood tocainide is 10-20% protein bound. The Volume of distribution is 2.5-3.5 L/kg. 30-50% is excret...

Read more Tonocard Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Tocainide

Recent Tonocard Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Tocainide
  • Tablet: 400mg, 600mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Tocainide or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 20 March 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA